Digestive Malignancies
Conditions
Interventions
Digestive Malignancies:none
Control group:None
Sponsors
Tianjin Medical University Cancer Institute and Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. All patients with gastrointestinal tumors are newly diagnosed, and no treatment has been administered before blood collection; 2. Primary gastrointestinal malignancies confirmed by histopathology; 3. All study participants voluntarily participated and signed informed consent; 4. Clinical data is complete and follow-up can be conducted; 5. Serum samples of the healthy control group are all stored in the sample bank; 6. Serum samples of patients with gastrointestinal tumors and liver cirrhosis are all stored in the sample bank; 7. Only cases with complete blood samples can be included in this study.
Exclusion criteria
Exclusion criteria: 1. Missing clinical information; 2. Tumor patients who have received treatment before the initial diagnosis; 3. Patients who develop other malignant tumors during follow-up and die from other malignant tumors;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Carbohydrate Antigen 19-9 ;Carcinoembryonic Antigen; | — |
Countries
China
Contacts
Public ContactRanliang Cui
Tianjin Medical University Cancer Institute and Hospital
Outcome results
None listed